Published in J Immunol on November 15, 2013
Mucosal-associated invariant T-cells: new players in anti-bacterial immunity. Front Immunol (2014) 1.19
Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers. J Exp Med (2015) 1.09
Check MAIT. J Immunol (2014) 1.03
Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites. J Immunol (2015) 0.96
A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage. Nat Immunol (2016) 0.94
The Role of Mucosal Associated Invariant T Cells in Antimicrobial Immunity. Front Immunol (2015) 0.90
Role of Innate T Cells in Anti-Bacterial Immunity. Front Immunol (2015) 0.90
MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis. Immunol Rev (2015) 0.89
Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation. J Clin Invest (2015) 0.87
NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module. PLoS Genet (2015) 0.86
Ontogeny of Innate T Lymphocytes - Some Innate Lymphocytes are More Innate than Others. Front Immunol (2014) 0.83
Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens. Nat Commun (2016) 0.82
The T cell antigen receptor: the Swiss army knife of the immune system. Clin Exp Immunol (2015) 0.82
CD1d- and MR1-Restricted T Cells in Sepsis. Front Immunol (2015) 0.81
MR1-Restricted Mucosal-Associated Invariant T Cells and Their Activation during Infectious Diseases. Front Immunol (2015) 0.80
Mucosal-Associated Invariant T Cells in Multiple Sclerosis: The Jury is Still Out. Front Immunol (2015) 0.80
Mucosal-associated invariant T cells from induced pluripotent stem cells: A novel approach for modeling human diseases. World J Stem Cells (2016) 0.78
Mucosal-associated invariant T cells in autoimmunity, immune-mediated diseases and airways disease. Immunology (2016) 0.78
Regulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic Potentials. Front Immunol (2015) 0.77
Structure and function of the non-classical major histocompatibility complex molecule MR1. Immunogenetics (2016) 0.75
Expression and trafficking of MHC related protein 1 (MR1). Immunology (2017) 0.75
The role of MHC class Ib-restricted T cells during infection. Immunogenetics (2016) 0.75
How MAIT cells get their start. Nat Immunol (2016) 0.75
MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules? Immunogenetics (2016) 0.75
Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol (2009) 5.83
Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease. J Clin Oncol (2011) 5.14
Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science (2003) 4.80
The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity (2008) 4.68
Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol (2010) 4.25
Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature (2003) 3.87
Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol (2002) 3.78
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol (2010) 3.76
Stepwise development of MAIT cells in mouse and human. PLoS Biol (2009) 3.18
Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol (2010) 3.15
Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood (2010) 3.06
CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood (2007) 2.68
Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat Med (2011) 2.48
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med (2005) 2.33
Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway. Nat Immunol (2002) 2.25
Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity (2007) 2.15
NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog (2005) 2.04
Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med (2013) 2.02
Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol (2011) 2.01
Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet (2005) 1.99
Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cell Microbiol (2009) 1.87
Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells. Blood (2011) 1.83
MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution. Proc Natl Acad Sci U S A (2009) 1.81
Nod2-dependent Th2 polarization of antigen-specific immunity. J Immunol (2008) 1.78
CD1d- and MR1-restricted invariant T cells: of mice and men. Curr Opin Immunol (2006) 1.77
Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet (2006) 1.74
Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. J Biol Chem (2005) 1.72
Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet (2001) 1.70
MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J Exp Med (2008) 1.67
The new species Brucella microti replicates in macrophages and causes death in murine models of infection. J Infect Dis (2010) 1.60
Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol (2006) 1.55
gamma(c) cytokines provide multiple homeostatic signals to naive CD4(+) T cells. Eur J Immunol (2007) 1.55
Dendritic cell maturation controls adhesion, synapse formation, and the duration of the interactions with naive T lymphocytes. J Immunol (2004) 1.49
Extrathymic induction of Foxp3⁺ regulatory T cells declines with age in a T-cell intrinsic manner. Eur J Immunol (2013) 1.45
Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Cancer Res (2010) 1.43
Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors. Clin Cancer Res (2010) 1.42
Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin. EMBO Rep (2005) 1.41
Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subset. Microbes Infect (2005) 1.40
Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice. Infect Immun (2007) 1.34
Are major histocompatibility complex molecules involved in the survival of naive CD4+ T cells? J Exp Med (2003) 1.34
Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3. J Clin Invest (2004) 1.33
Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int Immunol (2011) 1.33
MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. PLoS Pathog (2013) 1.32
MAIT cells, surveyors of a new class of antigen: development and functions. Curr Opin Immunol (2013) 1.30
An adaptive phase I design for identifying a biologically optimal dose for dual agent drug combinations. Stat Med (2007) 1.29
Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints. Cytotherapy (2013) 1.27
Nod1 and Nod2 regulation of inflammation in the Salmonella colitis model. Infect Immun (2010) 1.20
Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest (2015) 1.15
Three patterns of cytochrome P450 gene expression during liver maturation in mice. Drug Metab Dispos (2008) 1.15
Innate immune recognition at the epithelial barrier drives adaptive immunity: APCs take the back seat. Trends Immunol (2007) 1.12
Expansion of functional human mucosal-associated invariant T cells via reprogramming to pluripotency and redifferentiation. Cell Stem Cell (2013) 1.11
Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation. Mol Pharmacol (2009) 1.09
2,2'-[o-Phenylenebis(methylenethio)]bis(pyridine N-oxide). Acta Crystallogr Sect E Struct Rep Online (2009) 1.09
Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes. Arthritis Res Ther (2005) 1.07
A one-dimensional cadmium(II) complex supported by a sulfur-nitro-gen mixed-donor ligand. Acta Crystallogr Sect E Struct Rep Online (2009) 1.07
Skin carcinoma arising from donor cells in a kidney transplant recipient. Cancer Res (2005) 1.06
Prevalence of Salmonella on raw poultry at retail markets in China. J Food Prot (2011) 1.06
Nucleotide oligomerization domain-containing proteins instruct T cell helper type 2 immunity through stromal activation. Proc Natl Acad Sci U S A (2011) 1.05
The innate immune molecule, NOD1, regulates direct killing of Helicobacter pylori by antimicrobial peptides. Cell Microbiol (2009) 1.05
Molecular targets of epigenetic regulation and effectors of environmental influences. Toxicol Appl Pharmacol (2010) 1.05
IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts. PLoS Med (2008) 1.04
Antigen-specific T-T interactions regulate CD4 T-cell expansion. Blood (2008) 1.04
Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma. Int J Cancer (2013) 1.03
Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-γ. J Immunother (2011) 1.03
Thermosensitive copolymer networks modify gold nanoparticles for nanocomposite entrapment. Chemistry (2007) 1.03
Preferential binding of peptides to graphene edges and planes. J Am Chem Soc (2011) 1.03
Mutant mice lacking the p53 C-terminal domain model telomere syndromes. Cell Rep (2013) 1.02
MAIT cell recognition of MR1 on bacterially infected and uninfected cells. PLoS One (2013) 1.02
Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules. J Immunol (2004) 1.02
In vivo neuronal tracing with GFP-TTC gene delivery. Mol Cell Neurosci (2002) 1.00
Feto-maternal microchimerism in connective tissue diseases. Eur J Immunol (2002) 0.99
Human iNKT and MAIT cells exhibit a PLZF-dependent proapoptotic propensity that is counterbalanced by XIAP. Blood (2012) 0.97
Hypocrellin-loaded gold nanocages with high two-photon efficiency for photothermal/photodynamic cancer therapy in vitro. ACS Nano (2012) 0.96
Rapid, multiplexed microfluidic phage display. Lab Chip (2011) 0.95
Fabrication of protein nanotubes based on layer-by-layer assembly. Biomacromolecules (2006) 0.95
Transition of cationic dipeptide nanotubes into vesicles and oligonucleotide delivery. Angew Chem Int Ed Engl (2007) 0.94
Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared with placenta. Drug Metab Dispos (2008) 0.93
CD11c+ cells are required for antigen-induced increase of mast cells in the lung. J Immunol (2012) 0.93
Activation of p38 signaling in the microglia in the nucleus accumbens contributes to the acquisition and maintenance of morphine-induced conditioned place preference. Brain Behav Immun (2011) 0.90
Immobilization of glucose oxidase onto gold nanoparticles with enhanced thermostability. Biochem Biophys Res Commun (2007) 0.90
High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer. Cancer Res (2014) 0.89
Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients. PLoS One (2012) 0.89
Analysis of APC types involved in CD4 tolerance and regulatory T cell generation using reaggregated thymic organ cultures. J Immunol (2013) 0.87
Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation. J Clin Invest (2015) 0.87